CIRION Central Laboratory   Report issue

For profit Phase 3
Founded: Laval Canada (1994)
Status: Acquired by CERBA (2023)

Organization Overview

First Clinical Trial
2006
NCT00358566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

gemcitabine (gemzar) (1 trial)

gv 1001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2